BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29976277)

  • 1. Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.
    Liu ZJ; Hu GP; Fei MY; Yin Z; Shi QX; Sun F
    Chin Med Sci J; 2018 Jun; 33(2):84-90. PubMed ID: 29976277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarction.
    Huang CH; Chang CC; Kuo CL; Huang CS; Lin CS; Liu CS
    Int J Biol Sci; 2015; 11(1):38-47. PubMed ID: 25552928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention.
    Guo J; Zhang WZ; Zhao Q; Wo JS; Cai SL
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4457-4463. PubMed ID: 29077146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein and left ventricular remodeling in patients with acute myocardial infarction.
    Uehara K; Nomura M; Ozaki Y; Fujinaga H; Ikefuji H; Kimura M; Chikamori K; Nakaya Y; Ito S
    Heart Vessels; 2003 May; 18(2):67-74. PubMed ID: 12756602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
    Post S; Post MC; van den Branden BJ; Eefting FD; Goumans MJ; Stella PR; van Es HW; Wildbergh TX; Rensing BJ; Doevendans PA
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):756-65. PubMed ID: 22419603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
    Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
    Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction].
    Wang SL; Sun F; Zhao X; Chen LL; Feng GB; Yan CH; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Oct; 38(10):870-4. PubMed ID: 21176627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-contrast cardiac CT immediately after percutaneous coronary intervention: does it predict the risk of left ventricular remodeling in patients with ST-elevation myocardial infarction?
    Khurelsukh K; Kim YH; Seon HJ; Song JH; Park SY; Moon SM; Kim SH; Sim DS; Ahn Y
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():147-54. PubMed ID: 27139462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
    Squire IB; Evans J; Ng LL; Loftus IM; Thompson MM
    J Card Fail; 2004 Aug; 10(4):328-33. PubMed ID: 15309700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
    Shehata M; Fayez G; Nassar A
    Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
    Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F
    Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does spironolactone have a dose-dependent effect on left ventricular remodeling in patients with preserved left ventricular function after an acute myocardial infarction?
    Vatankulu MA; Bacaksiz A; Sonmez O; Alihanoglu Y; Koc F; Demir K; Gul EE; Turfan M; Tasal A; Kayrak M; Yazici M; Ozdemir K
    Cardiovasc Ther; 2013 Aug; 31(4):224-9. PubMed ID: 22963506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction.
    Yokota T; Tomita H; Mori Y; Kudo T; Hiraga H; Suto N; Higuma T; Abe N; Hanada H; Osanai T; Okumura K
    J Cardiovasc Pharmacol; 2014 Jun; 63(6):528-32. PubMed ID: 24709636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
    J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study.
    Kelly D; Cockerill G; Ng LL; Thompson M; Khan S; Samani NJ; Squire IB
    Eur Heart J; 2007 Mar; 28(6):711-8. PubMed ID: 17339265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.
    Kitaoka H; Kubo T; Okawa M; Takenaka N; Baba Y; Yamasaki N; Matsumura Y; Furuno T; Doi YL
    J Cardiol; 2011 Nov; 58(3):261-5. PubMed ID: 21890325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
    Fujiwara T; Matsunaga T; Kameda K; Abe N; Ono H; Higuma T; Yokoyama J; Hanada H; Osanai T; Okumura K
    Heart Vessels; 2007 Sep; 22(5):303-9. PubMed ID: 17879021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.